Objectives: To synthesize the evidence of existential interventions in adult patients with cancer.
| BACKGROUND
During the last decades, a shift has been made in the treatment of cancer patients from focusing on physical symptoms to seeing patients as holistic human beings with physical, psychosocial, and spiritual needs. 1, 2 To be diagnosed with a life-threatening disease such as cancer can be a deeply unsettling experience that may raise existential concerns. 3 While some cancer patients experience their illness as an opportunity for personal growth, 4, 5 others might find it hard to find answers to their questions, possibly resulting in decreased psychological and spiritual well-being. 6 Spiritual well-being refers to the construct of spirituality, which can be further divided into two subcomponents: a religious component, referring to one's faith, and an existential component, referring to one's sense of meaning and purpose in life. 7, 8 Spiritual well-being has been associated with several patient outcomes. A high level of spiritual well-being can help cancer patients cope with their illness, 9 enhance quality of life, 10 and protect against end-of-life despair. [11] [12] [13] On the other hand, existential distress may lead to a state of demoralization, which is characterized by feelings of losing meaning, hope, or dignity and by a desire for hastened death. 11, 12 Additionally, anxiety and depression are prevalent in cancer populations 14 and have been negatively associated with spiritual well-being and positively with demoralization. 12, 15, 16 Depression is furthermore linked to physical symptoms such as pain, 17 which is experienced by most cancer patients at some point. 18, 19 Therefore, physical, psychological, and spiritual well-being seem to be connected and should all in one be considered by interventions addressing existential needs and concerns of cancer patients. Meanwhile, a variety of such interventions has been developed and evaluated, stemming from different conceptual bases like existential psychotherapy or logotherapy. [20] [21] [22] While psycho-oncologic interventions in general have been shown to reduce emotional distress and increase quality of life, 23 few meta-analyses have specifically provided evidence for the efficacy of existential interventions. [24] [25] [26] [27] Oh and Kim 24 demonstrated significant effects of spiritual interventions on spiritual well-being, meaning, and depression in patients with cancer. They included only five studies on meaning-centred psychotherapy with the other studies evaluating religious interventions. Vos et al 26 reviewed studies on existential therapies up to the year 2010. Populations were mixed consisting of medically ill and non-ill participants. Interventions such as hope programs, life review, or dignity therapy were not included. They found no to moderate effects on aggregated outcomes of meaning, psychopathology, self-efficacy, and physical well-being. In a metaanalysis by Kruizinga et al, 25 a moderate short-term effect of existential interventions on quality of life of patients with cancer was found. Quality of life was the only outcome of this review, and again some types of interventions were not included (eg, supportiveexpressive psychotherapy, hope interventions). Wang et al 27 conducted a meta-analysis on the effects of life review interventions in patients with advanced cancer. They found small to large effects on meaning, distress, and quality of life. However, these effects diminished when excluding outlier studies from the analysis. Hence, the impact of existential interventions on spiritual, psychological, and physical outcomes in patients with cancer is still largely unclear.
Potential moderators such as cancer stage and type or intervention concepts have been scarcely explored. Because existential distress may occur at any time in the course of a cancer disease 3 and have significant impact on patients' lives, exploring the effectiveness of existential interventions across the cancer trajectory is of high relevance. 28, 29 The aims of the current systematic review and meta-analysis were therefore:
1. To synthesize the evidence and evaluate the efficacy of existential interventions in adult patients with cancer of all stages, including survivors, in comparison to no treatment, wait-list, active control, or attention/psychological placebo.
2. To present pooled estimates of the effects of existential interventions on a wide range of patient outcomes at different time points, including indicators of spiritual, psychological, and physical well-being.
3. To identify and explore cancer-specific and general factors that might moderate the effects of existential interventions and account for heterogeneity.
| METHODS
The present systematic review has been registered with Prospero (registration number CRD42016042895) and was guided by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement 30 (for PRISMA checklist see Appendix A).
| Eligibility criteria
Studies were considered eligible if they (1) focused on adult (age ≥ 18) patients with cancer of any type and stage, (2) investigated an existential intervention, (3) compared with an active control, attention placebo, no treatment or wait list, (4) reported quantitative data on one of the outcomes of interest to this review, assessed at least once post-treatment by using validated scales, and (5) were conducted as randomized controlled trials. Non-randomized controlled trials were to be included as defined in the initial study protocol. During the process of building the search strategy, it became clear that there is already a high amount of randomized controlled trials available in this field. To increase the quality of evidence, it was thus decided to only include randomized controlled trials. Interventions had to be manualized and address existential needs as a main component, for example by creating meaning, fostering hope or dignity, or by supporting patients in expressing their feelings and fears towards the end of life. Body-mind-spirit interventions (eg, with a focus on yoga, tai chi or meditation) and interventions with a strong focus on religious topics were not regarded as existential interventions. Study samples had to be composed of at least 90% cancer patients or survivors.
Primary outcomes were patient-reported spiritual well-being and symptom severities of anxiety and depression. Secondary outcomes comprised patient-reported existential well-being, quality of life, hope, desire for hastened death, self-efficacy, physical well-being, and pain.
It was also assessed whether studies reported adverse effects related to the interventions or not. Publications reported in the German or English language were included. 34 and outcome assessors were participants themselves, evaluations on these two domains are not provided.
| Search strategy

| Data synthesis
Data analyses were conducted using RevMan 5.3 35 and the latest R software along with the metafor package. 36 Between-group standardized mean differences (Hedges' g) with their accompanying 95% confidence intervals were used as effect estimates. Positive effect estimates represent effects in favor of the existential intervention on all outcomes. An effect size of g = 0.2 was considered as small, g = 0.5 as moderate, and g = 0.8 as large. 37 Effects were pooled within four time horizons: post-treatment (≤1 month post intervention),
short-term follow-up (≤3 months post intervention), medium-term follow-up (≤6 months post intervention), and long-term follow-up (>6 months post intervention). If there was more than one assessment within the same time horizon within a study, the latest assessment was selected. If the same outcome was assessed by multiple instruments of the same hierarchy level within a study, the instrument that had been used most frequently across studies was selected. If a study included more than one intervention or control group, all groups were combined or split using the formulae given in the Cochrane Handbook of Systematic Reviews. 38 As some heterogeneity across studies was expected due to differences in intervention concepts, patient characteristics, and outcome instruments, all meta-analyses were conducted using random effects models. 38 Heterogeneity was assessed by visual inspection of forest plots, Q-tests of heterogeneity, and the I 2 statistic.
According to the Cochrane Handbook of Systematic Reviews, an I 2 > 60% can be regarded as substantial, and results should be interpreted with caution. 38 A priori defined moderators were investigated by applying subgroup analyses (categorical moderators) and meta-regression (continuous moderators) in order to identify potential sources of substantial heterogeneity. Moderator analyses were conducted only for meta-analyses including at least 10 effect sizes.
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Publication bias was assessed by visual inspection of funnel plots and Egger's tests where at least 10 effect sizes could be included. 39, 40 Sensitivity analyses were carried out accounting for a high risk of bias, baseline differences, and selection of follow-up. A P value less than 0.05 was regarded as statistically significant.
3 | RESULTS
| Study selection
The study selection process is outlined in Figure 1 . A total of 3461 records were identified by database searches. Of the 2130 records remaining after removal of duplicates, 1950 records could be excluded by screening titles and abstracts. A total of 180 full-texts were screened, resulting in 30 unique studies meeting the eligibility criteria.
Reasons for exclusions are given in Figure 1 . Main findings of six of the eligible studies are presented descriptively in a qualitative synthesis. [41] [42] [43] [44] [45] [46] [47] The remaining 24 studies were included in a quantitative synthesis.
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| Study characteristics
Studies included at total of 4121 participants with an overall mean age of 57 years (for an overview of study characteristics see Table 1 ). Table 1 ). Apart from the outcomes relevant to this review, studies investigated an even wider range of outcomes, including for example dignity-related distress or survival. Nine studies were judged as high at risk of bias (high on at least one domain), 18 as moderate (unclear on at least one domain), and three as low (low on all domains). The majority of studies (k = 22) met the random sequence generation criterion, and 14 studies met the allocation concealment criterion (for risk of bias assessment see Figure 2 ).
| Quantitative synthesis
Effect sizes, 95% confidence intervals, I 2 statistics, and numbers of included studies are summarized for each outcome and time horizon in Table 2 . Forest plots of primary outcomes at post-treatment are shown in Figure 3 .
Effect sizes at post-treatment
At post-treatment, no significant differences were found between existential interventions and control groups in spiritual well-being k = 2; I 2 = 0%). Tests for heterogeneity were significant for all outcomes except desire for hastened death (P = 0.57) and self-efficacy (P = 0.66).
Effect sizes at short-term follow-up
At 3 months post-treatment, none of the pooled effect sizes reached statistical significance. Effect sizes were moderate in to 0.80), and mean age of participants (P = 0.12 to 0.97).
Sensitivity analyses
Only randomized controlled trials were included in this review.
Nonetheless, there were significant baseline differences between experimental groups on multiple outcome variables in few studies, 46, 48, 64, 65, 69 heterogeneity is substantial as is the case here. 71 Therefore, one cannot rule out the possibility of publication bias.
| Qualitative synthesis
Of the studies not included in meta-analyses, five studies investigated effects of supportive-expressive group therapy in women with metastatic 41, 43, 47, 72, 73 and non-metastatic 42 breast cancer. Two studies conducted a life review, and one of them compared life review also to dignity therapy. 45, 46 No significant effects were found on selfefficacy (k = 2) or physical well-being (k = 1). One study observed significant effects in depression and anxiety that diminished by taking , measure of heterogeneity; CI, confidence interval; DHD, desire for hastened death; EWB, existential well-being; PWB, physical well-being; QoL, quality of life; SE, self-efficacy; SWB, spiritual well-being. baseline scores into account. In another study anxiety was significantly reduced by supportive-expressive group therapy. In one study depression could be reduced by a life review intervention. Two studies investigating hope found no significant effects. Supportive-expressive group therapy significantly reduced pain intensity in one study and did not so in another. Quality of life was not affected by dignity therapy or life review in one study. In sum, a similar pattern of variability in intervention effects can be seen in these studies as in meta-analyses.
| Adverse effects
None of the included studies systematically evaluated adverse effects related to the existential interventions, and the majority did not seem to consider this aspect at all. Henry et al 53 reported that one participant dropped out because of feeling distressed by the loss of defensive denial due to the intervention. Chochinov et al 54 reported that some family members were unhappy with the generativity document derived from dignity therapy, because it painted a distorted picture of the participants.
| DISCUSSION
The aims of the present study were to summarize and quantify the effects of existential interventions on spiritual, psychological, and physical well-being in adult patients with cancer and to identify potentially moderating factors. Results indicate that existential interventions might be suited to improve existential well-being and quality of life in the short term, hope in the short term and at 6 months, and self-efficacy in the short term. Follow-ups in the medium and long term were scarce. Some of the variability in effects might further be explained by differences in intervention concepts, patient settings, or professional backgrounds of therapists. The later findings should be The results on existential well-being, quality of life, and selfefficacy correspond to similar findings in previous studies [24] [25] [26] [27] and are strengthened by inclusion of a wide range of intervention concepts and a focus on patients with cancer at any stage in the present review. The finding that quality of life can be improved by existential interventions is in line with the meta-analysis by Faller et al, 23 who also found small to moderate effects on quality of life. By contrast, the present review did not find that this effect is maintained over time. The overall contribution of existential interventions to hope in patients with cancer had not yet been quantified. This result is promising, because hopelessness acts as a unique risk factor for developing depression, demoralization syndrome, and desire for death in cancer patients. 74, 75 Further, hope is associated with quality of life and may help cancer patients to adequately cope with their illness.
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In contrast to Oh and Kim, 24 the present review did not find effects on spiritual well-being, depression, and anxiety. This can be explained by the use of different eligibility criteria. Subgroup analyses by Oh and Kim 24 showed the effects on spiritual well-being and depression appeared only in religious interventions, and depression and anxiety
were not affected when non-randomized studies were excluded. In the present review, only randomized controlled trials were included, and religious interventions were explicitly excluded to identify the unique contributions of existential interventions. Taken together, this gives evidence to the assumptions that existential interventions address the existential component of spiritual well-being rather than faith. The inconclusive results regarding depression and anxiety are, however, surprising, given the effects in existential well-being, quality of life, and hope and their interplay with psychological distress. In other meta-analyses, the effects on depression and anxiety became insignificant after excluding a subset of studies from the analyses. 24, 27 In the present review, the effects on depression and anxiety became significant after excluding studies with baseline differences in the outcomes from the analyses, indicating that attention should be paid to randomization and recruitment procedures. Therefore, the findings presented here do not necessarily mean that existential interventions are ineffective for anxiety and depression, but rather reflect the high amount of heterogeneity between studies. The evidence base regarding desire for hastened death, pain, and self-efficacy was too scarce to draw any firm conclusions. Likewise, studies barely reported on long-term or adverse effects of the interventions. As cancer becomes more and more a chronic condition and more patients survive, 77 long-term assessments of desirable and adverse effects would provide valuable information.
No moderator effects for cancer stage or type were found in this review, indicating that indeed patients of all cancer stages and types might benefit from existential interventions as they are all prone to experience existential distress. 3, 28, 29 It should be kept in mind, however, that existential issues might vary substantially during the course of the disease, which should be addressed by existential interventions.
| Implications
Interventions with different underlying concepts showed different effects in this review. Results indicate that life reviews might in particular be a beneficial component as they yield large effect sizes.
However, these results are based on exploratory analyses and a small number of studies and should thus be interpreted with caution. The variety of intervention concepts can nonetheless be used to deliver interventions that are tailored to individual patient needs. This however would require to comprehensively assess patient needs and levels of existential distress with tailored assessment instruments in advance. Generic and widely used outcome measures have the advantage of being more comparable between studies, whereas tailored outcome measures, although less common, may offer greater specificity of effects and mechanisms and possibly even larger effect sizes. In any case, outcome measures should be chosen after careful consideration and with a clear rationale, taking into account the focus of research question, validity, and responsiveness to change. 78 Terminally ill and physically weakened patients might also perceive it as a burden to fill out long multi-item questionnaires. In this case, it may be wiser to reduce assessments to only few well selected outcomes with disease-specific measures instead of using multiple single items that are not well validated. These aspects might also contribute to a reduction in clinical and statistical heterogeneity.
Developers of existential interventions are therefore best advised to build on sound theoretical assumptions and models of how constructs are interrelated and might be affected by the intervention. However, data were carefully checked by the second reviewer, and all results were discussed. Third, the data extraction process was guided by a-priori made decisions such as the choice of the most frequently used assessment instrument, the latest follow-up, or including studies with existential interventions as control groups. Different choices might have resulted in larger effect sizes. Although this was partly addressed in the present review by conducting sensitivity analyses, future research might further explore relevant aspects that have an impact on effects. Fourth, although only two studies showed significant baseline differences, some non-significant differences were also apparent in other studies at baseline. Considering these differences, using effect estimates based on changes from baseline might have led to different results. This method does however not necessarily arrive at unbiased estimates due to regression to the mean and the Cochrane Handbook of Systematic Reviews does not recommend using change scores in the first instance. 38, 83 Finally, because all included studies are published in English, there might be a bias due to excluding studies in different languages.
| CONCLUSION
The present systematic review and meta-analysis provides the latest evidence that existential interventions can improve patient outcomes in the short-term in adult patients with cancer of all stages and types.
More high quality studies that are less heterogeneous are needed to confirm these findings. Therefore, future research on existential interventions should strive towards a higher standardization in particular with respect to outcome assessments. Future research should also examine potential ways of increasing the effectiveness of those interventions or lowering the necessary resources for providing them by using modern technologies. 83 
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